Research Article
Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in Rural Northeast China: 2008 to 2018
Table 2
Prevalence of normal, prehypertension, stage 1, stage 2, and stage 3 and their percentage change by sex in rural northeast China, 2008-2018.
| Age groups (years) | Men | Women | Total | for men | for women | for total | 2008 | 2018 | Change (%) | 2008 | 2018 | Change (%) | 2008 | 2018 | Change (%) |
| Normal | | | | | | | | | | | | | 40-49 | 19.3 | 14.6 | -24.0 | 33.9 | 28.6 | -15.7 | 26.9 | 23.7 | -11.7 | 0.003 | <0.001 | 0.003 | 50-59 | 15.6 | 12.1 | -22.6 | 21.8 | 14.2 | -34.9 | 18.8 | 13.4 | -28.7 | 0.001 | <0.001 | <0.001 | 60-69 | 13.0 | 9.1 | -29.8 | 14.5 | 9.1 | -37.4 | 13.8 | 9.1 | -33.8 | <0.001 | <0.001 | <0.001 | 70-79 | 10.1 | 4.0 | -60.5 | 10.0 | 8.4 | -16.1 | 10.1 | 6.4 | -36.8 | <0.001 | 0.14 | <0.001 | ≥80 | 8.9 | 5.6 | -37.7 | 7.4 | 4.0 | -44.9 | 8.1 | 4.7 | -41.9 | 0.192 | 0.128 | 0.042 | Total | 15.9 | 9.8 | -38.4 | 23.9 | 14.1 | -41.0 | 20.0 | 12.4 | -38.0 | <0.001 | <0.001 | <0.001 | | 15.9 | 11.6 | -27.0 | 23.5 | 18.0 | -23.4 | 19.9 | 15.8 | -20.6 | | | | Prehypertension | | | | | | | | | | | | | 40-49 | 52.8 | 40.5 | -23.1 | 37.6 | 37.1 | -1.2 | 44.9 | 38.3 | -14.6 | <0.001 | 0.745 | <0.001 | 50-59 | 42.6 | 36.0 | -15.3 | 32.1 | 34.4 | 7.3 | 37.1 | 35.0 | -5.7 | <0.001 | 0.028 | 0.015 | 60-69 | 33.6 | 28.4 | -15.5 | 25.8 | 23.6 | -8.2 | 29.7 | 25.7 | -13.7 | <0.001 | 0.036 | <0.001 | 70-79 | 25.2 | 20.2 | -20.0 | 20.8 | 14.7 | -29.4 | 23.1 | 17.2 | -25.5 | 0.003 | <0.001 | <0.001 | ≥80 | 24.1 | 21.5 | -10.7 | 18.6 | 16.2 | -12.8 | 21.4 | 18.6 | -12.9 | 0.519 | 0.48 | 0.29 | Total | 42.8 | 30.7 | -28.3 | 32.0 | 28.2 | -11.9 | 37.3 | 29.2 | -21.7 | <0.001 | <0.001 | <0.001 | ASR | 42.9 | 34.6 | -19.3 | 31.4 | 30.8 | -1.9 | 37.0 | 32.3 | -12.7 | | | | Stage 1 | | | | | | | | | | | | | 40-49 | 18.5 | 27.6 | 49.5 | 16.7 | 22.5 | 34.9 | 17.5 | 24.3 | 38.5 | <0.001 | <0.001 | <0.001 | 50-59 | 24.1 | 29.4 | 21.7 | 23.3 | 27.2 | 16.6 | 23.7 | 28.0 | 18.1 | <0.001 | <0.001 | <0.001 | 60-69 | 27.8 | 31.5 | 13.1 | 26.4 | 31.6 | 19.5 | 27.1 | 31.5 | 16.2 | 0.002 | <0.001 | <0.001 | 70-79 | 30.8 | 34.9 | 13.2 | 27.1 | 28.2 | 4.4 | 29.0 | 31.3 | 7.9 | 0.024 | 0.468 | 0.059 | ≥80 | 31.5 | 34.0 | 8.0 | 25.3 | 27.2 | 7.2 | 28.4 | 30.3 | 6.5 | 0.564 | 0.634 | 0.528 | Total | 23.5 | 31.0 | 31.9 | 21.7 | 27.9 | 28.6 | 22.6 | 29.2 | 29.2 | <0.001 | <0.001 | <0.001 | ASR | 23.3 | 29.7 | 27.5 | 21.7 | 26.2 | 20.7 | 22.5 | 27.5 | 22.2 | | | | Stage 2 | | | | | | | | | | | | | 40-49 | 6.2 | 12.2 | 95.6 | 7.8 | 8.2 | 4.2 | 7.1 | 9.6 | 35.5 | <0.001 | 0.673 | <0.001 | 50-59 | 11.6 | 16.2 | 39.4 | 14.3 | 16.9 | 17.9 | 13.0 | 16.6 | 27.7 | <0.001 | 0.002 | <0.001 | 60-69 | 16.9 | 21.6 | 27.6 | 20.6 | 21.9 | 6.3 | 18.7 | 21.7 | 16.1 | <0.001 | 0.17 | <0.001 | 70-79 | 21.5 | 25.5 | 18.8 | 24.4 | 29.4 | 20.2 | 22.9 | 27.6 | 20.5 | 0.012 | 0.002 | <0.001 | ≥80 | 19.7 | 22.9 | 16.1 | 27.9 | 29.5 | 5.8 | 23.8 | 26.5 | 11.5 | 0.401 | 0.681 | 0.319 | Total | 11.6 | 19.4 | 67.2 | 13.9 | 18.9 | 36.0 | 12.8 | 19.1 | 49.2 | <0.001 | <0.001 | <0.001 | ASR | 11.5 | 16.6 | 44.3 | 14.5 | 16.1 | 11.0 | 13.0 | 16.1 | 23.8 | | | | Stage 3 | | | | | | | | | | | | | 40-49 | 3.3 | 5.0 | 52.3 | 4.0 | 3.6 | -9.4 | 3.6 | 4.1 | 12.3 | 0.015 | 0.515 | 0.31 | 50-59 | 6.1 | 6.3 | 3.8 | 8.6 | 7.4 | -13.9 | 7.4 | 7.0 | -5.3 | 0.744 | 0.062 | 0.41 | 60-69 | 8.7 | 9.5 | 9.0 | 12.7 | 13.8 | 8.7 | 10.7 | 12.0 | 12.1 | 0.297 | 0.153 | 0.017 | 70-79 | 12.3 | 15.4 | 24.8 | 17.7 | 19.3 | 9.0 | 14.9 | 17.5 | 17.5 | 0.019 | 0.256 | 0.007 | ≥80 | 15.7 | 16.0 | 1.4 | 20.9 | 23.1 | 10.7 | 18.3 | 19.9 | 8.6 | 0.948 | 0.536 | 0.527 | Total | 6.2 | 9.2 | 48.4 | 8.4 | 10.8 | 28.6 | 7.3 | 10.2 | 39.7 | <0.001 | <0.001 | <0.001 | ASR | 6.3 | 7.5 | 19.0 | 8.9 | 8.9 | 0.0 | 7.6 | 8.2 | 7.9 | | | |
|
|